Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
AssigneeG.D. Searle & Co.
InventorsBradley T. Keller, Kevin C. Glenn, Joseph R. Schuh
Life of this patent
Estimating the term…
Abstract
The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an ileal bile acid transport inhibitor combined with a fibric acid derivative.
Claims13
A therapeutic combination comprising a first amount of an ileal bile acid transport inhibiting compound and a second amount of a fibric acid derivative compound wherein the first amount and the second amount together comprise an anti-hyperlipidemic condition effective amount, an anti-atherosclerotic condition effective amount, or an anti-hypercholesterolemic condition effective amount of the compounds,
- wherein said ileal bile acid transport inhibiting compound comprises compound B-5 represented by:
- or an enantiomer or a racemate thereof.
A method for the prophylaxis or treatment of a hyperlipidemic condition comprising administering to a patient in need thereof a combination in unit dosage form wherein the combination comprises a first amount of an ileal bile acid transport inhibiting compound and a second amount of a fibric acid derivative compound wherein the first amount and the second amount together comprise an anti-hyperlipidemic condition effective amount of the compounds,
- wherein said ileal bile acid transport inhibiting compound is represented by formula (B-5):
- or enantiomers or racemates thereof.
A method for the prophylaxis or treatment of a hyperlipidemic condition comprising administering to a patient in need thereof a combination in unit dosage form wherein the combination comprises a first amount of an ileal bile acid transport inhibiting compound and a second amount of a fibric acid derivative compound wherein the first amount and the second amount together comprise an anti-atherosclerotic condition effective amount of the compounds,
- wherein said ileal bile acid transport inhibiting compound is represented by formula (B-5):
- or enantiomers or racemates thereof.
A method for the prophylaxis or treatment of a hyperlipidemic condition comprising administering to a patient in need thereof a combination in unit dosage form wherein the combination comprises a first amount of an ileal bile acid transport inhibiting compound and a second amount of a fibric acid derivative compound wherein the first amount and the second amount together comprise an anti-hypercholesterolemic condition effective amount of the compounds,
- wherein said ileal bile acid transport inhibiting compound is represented by formula (B-5):
- or enantiomers or racemates thereof.
Dependencies are inferred from the claim text.